IDB 1056
Alternative Names: Delphinidin chlorideLatest Information Update: 22 Aug 2007
At a glance
- Originator Inverni della Beffa
- Developer Indena; Inverni della Beffa
- Class Antihyperglycaemics; Small molecules; Vascular disorder therapies; Vasodilators
- Mechanism of Action Cell membrane permeability inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic angiopathies; Varicose veins; Venous insufficiency
Most Recent Events
- 31 Aug 1999 No-Development-Reported for Varicose veins in Italy (Unknown route)
- 31 Aug 1999 No-Development-Reported for Venous insufficiency in Italy (Unknown route)
- 14 Jul 1998 No-Development-Reported for Diabetic angiopathies in Italy (Unknown route)